Clinical Trials Directory

Trials / Completed

CompletedNCT03176706

Assessment of Dried Blood Spot Thyroglobulin and Urinary Iodine Concentration in Pregnant Women

Assessment of Dried Blood Spot Thyroglobulin in Pregnant Women to Redefine the Range of Median Urinary Iodine Concentration That Indicates Adequate Iodine Intake

Status
Completed
Phase
Study type
Observational
Enrollment
2,900 (actual)
Sponsor
Swiss Federal Institute of Technology · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

To avoid iodine deficiency and its consequences in pregnant women and their offspring, women should reach a sufficient iodine intake long before conception. To monitor iodine status, median urinary iodine concentration (UIC) is widely used in pregnant women (PW). Thyroglobulin (Tg) us another marker used to assess iodine status . In this study, urine samples as well as dried blood spots will be collected to measure UIC and Tg (as well as other hormones to define thyroid function) in PW. The results shall be used to reassess the threshold which defines iodine status in PW according to UIC.

Conditions

Interventions

TypeNameDescription
OTHERno interventionthis is a completely observational study, NO INTERVENTION

Timeline

Start date
2017-08-09
Primary completion
2019-08-31
Completion
2019-08-31
First posted
2017-06-05
Last updated
2020-05-13

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT03176706. Inclusion in this directory is not an endorsement.